Scotia Capital Inc. Eli Lilly & CO Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

A detailed history of Scotia Capital Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Scotia Capital Inc. holds 94,264 shares of LLY stock, worth $73.4 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

94,264

Previous 66,585 41.57%

Holding current value

$73.4 Million

Previous $60.3 Million 38.53%

% of portfolio

0.47%

Previous 0.36%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $21.4 Million - $26.6 Million	27,679 Added 41.57%	94,264 $83.5 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $5.76 Million - $7.22 Million	7,941 Added 13.54%	66,585 $60.3 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $6.98 Million - $9.34 Million	11,791 Added 25.17%	58,644 $45.6 Million
Q4 2023 Feb 12, 2024	BUY	$525.19 - $619.13 $1.83 Million - $2.15 Million	3,478 Added 8.02%	46,853 $27.3 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $2.65 Million - $3.65 Million	6,087 Added 16.32%	43,375 $23.3 Million
Q2 2023 Aug 03, 2023	BUY	$350.74 - $468.98 $344,075 - $460,069	981 Added 2.7%	37,288 $17.5 Million
Q1 2023 May 11, 2023	BUY	$310.63 - $364.82 $615,358 - $722,708	1,981 Added 5.77%	36,307 $12.5 Million
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $89,069 - $103,783	277 Added 0.81%	34,326 $12.6 Million
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $3.9 Million - $4.45 Million	-13,166 Reduced 27.89%	34,049 $11 Million
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $668,673 - $785,120	2,399 Added 5.35%	47,215 $15.3 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $587,898 - $730,608	2,505 Added 5.92%	44,816 $12.8 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $625,083 - $775,731	-2,780 Reduced 6.17%	42,311 $11.7 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $3.73 Million - $4.59 Million	16,849 Added 59.66%	45,091 $10.4 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $98,941 - $127,979	548 Added 1.98%	28,242 $6.48 Million
Q1 2021 May 06, 2021	BUY	$164.32 - $212.72 $33,028 - $42,756	201 Added 0.73%	27,694 $5.17 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $97,323 - $128,781	-746 Reduced 2.64%	27,493 $4.64 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $1.02 Million - $1.18 Million	-6,949 Reduced 19.75%	28,239 $4.18 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $1.4 Million - $1.68 Million	10,240 Added 41.05%	35,188 $5.78 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $1.12 Million - $1.39 Million	-9,404 Reduced 27.38%	24,948 $3.46 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $192,135 - $237,976	-1,797 Reduced 4.97%	34,352 $4.52 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $22,105 - $24,045	-207 Reduced 0.57%	36,149 $4.04 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $174,937 - $204,196	-1,579 Reduced 4.16%	36,356 $4.03 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $3.54 Million - $4.17 Million	-31,846 Reduced 45.64%	37,935 $4.92 Million
Q4 2018 Feb 11, 2019	BUY	$105.9 - $118.64 $1.61 Million - $1.81 Million	15,221 Added 27.9%	69,781 $8.07 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $3.38 Million - $4.22 Million	-39,350 Reduced 41.9%	54,560 $5.86 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $84,481 - $96,958	1,116 Added 1.2%	93,910 $7.23 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $2.41 Million - $2.85 Million	-32,524 Reduced 25.95%	92,794 $7.18 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $1.43 Million - $1.53 Million	17,465 Added 16.19%	125,318 $10.6 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $653,014 - $724,780	8,473 Added 8.53%	107,853 $9.23 Million
Q2 2017 Aug 15, 2017	BUY	N/A	99,380	99,380 $8.18 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Eli Lilly & CO Transaction History